De-escalated neoadjuvant nab-paclitaxel combined with pyrotinib and trastuzumab in intrinsic HER2-enriched breast cancer (NJMU-BC01): a multicenter, single-arm, phase 2 trial

Authors

Institutions

Publication Details

Journal
EClinicalMedicine
Published
2025-07-19
DOI
https://doi.org/10.1016/j.eclinm.2025.103376
Citations
1
Primary Topic
HER2/EGFR in Cancer Research
Type
article
Field-Weighted Citation Impact
1.05
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

De-escalated neoadjuvant nab-paclitaxel combined with pyrotinib and trastuzumab in intrinsic HER2-enriched breast cancer (NJMU-BC01): a multicenter, single-arm, phase 2 trial

Xiaoan Liu, Min Zha, Tiansong Xia, Shui Wang et al.
1 citations
EClinicalMedicine
HER2/EGFR in Cancer Research
1.05
article

De-escalated neoadjuvant nab-paclitaxel combined with pyrotinib and trastuzumab in intrinsic HER2-enriched breast cancer (NJMU-BC01): a multicenter, single-arm, phase 2 trial

Xiaoan Liu, Min Zha, Tiansong Xia, Shui Wang, Wenbin Zhou, Hui Xie, Qiang Ding, Cong Wang, Yi Ren, Xiaoming Zha, Zhao Liu, Lin Chen, Wei Li, Tao Jing, Yi Zhao, Hua Pan, Yue Sun, Hong Pan, Mingduo Liu
article en
1 citations

Abstract

No abstract available for this paper.
EClinicalMedicineVol. 86
Xuzhou Medical College (CN), Huaian First People’s Hospital (CN), Deyang Stomatological Hospital (CN), Second Affiliated Hospital of Nanjing Medical University (CN), Liuyang City Maternal and Child Health Hospital (CN), Nanjing Medical University (CN)
Good health and well-being
Openalex Percentile: Top 19%
HER2/EGFR in Cancer Research
1.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.